**Executive Summary**
The 16th India Probiotic Symposium was held in New Delhi on March 27–28, 2026, focusing on the impact of gut microbiome and probiotics on health across all ages. Shri Rajiv Gauba of NITI Aayog emphasized the critical link between gut health, national immunity, and economic productivity, noting that 56.4% of India's disease burden stems from unhealthy diets. Key action items include leveraging digital health tools, combating market misinformation, and fostering collaboration to develop clinically validated probiotic products.
**Key Points / Main Content**
**Dietary and Public Health Trends**
* Urbanization and social media-driven lifestyles have led to a rapid shift toward ultra-processed and refined foods.
* Unhealthy or imbalanced diets are responsible for an estimated 56.4% of the disease burden in India.
* Neglecting gut health at a microscopic level can lead to significant macroscopic consequences for national health.
**Economic and Healthcare Progress**
* Health is identified as a critical sector for both individual well-being and the realization of India’s demographic dividend.
* Government initiatives like Ayushman Bharat and PM-JAY have reduced out-of-pocket health expenditure from 62.6% (FY15) to 39.4% (FY22).
* These healthcare improvements have resulted in household savings exceeding ₹1.25 lakh crore.
**Scientific and Technological Frontiers**
* Microbiome science is shifting from descriptive studies to mechanistic and translational research.
* Emerging fields include CRISPR-enabled engineering of probiotic strains, synthetic biology, and next-generation microbiome-based therapeutics for precision medicine.
* The use of digital health tools, AI, and data analytics is essential to expand specialist care to underserved communities.
**Strategic Goals and Challenges**
* India is positioned to lead the global probiotic movement by integrating traditional fermented food knowledge with modern genomic research.
* There is a critical need to address persistent challenges in healthcare access, equity, and the shortage of skilled professionals.
* Robust collaboration between academia, industry, and regulators is required to ensure products are safe and effective.
**Impact Analysis**
**Healthcare Professionals**
**Impact**
They are central to expanding specialist care and managing the transition toward preventive healthcare and affordable treatment.
**Action Required**
Must increase the prescription of affordable generic medicines, adopt digital tools like telemedicine and AI, and act as advocates for those lacking medical access.
**Researchers and Innovators**
**Impact**
They drive the scientific progression toward precision medicine and clinically validated probiotics.
**Action Required**
Adopt multidisciplinary and evidence-based approaches to address complex health challenges and bridge the gap between traditional knowledge and genomic research.
**Industry and Regulators**
**Impact**
These stakeholders are responsible for the quality, safety, and veracity of products available in the probiotics and supplements market.
**Action Required**
Collaborate to translate scientific advances into accessible products and take active measures to counter misinformation and misleading advertisements.
**The General Public**
**Impact**
Directly affected by the rising burden of lifestyle diseases and the costs of healthcare.
**Action Required**
Shift back toward traditional, nutritionally rich diets and adopt preventive lifestyles to reduce the need for expensive diagnostics and procedures.
Key Entities Referenced
16th India Probiotic Symposium: A national conference focused on gut microbiome science and its impact on public health, preventive healthcare, and disease management.
Gut Microbiota and Probiotic Science Foundation: The primary organization responsible for organizing the symposium and advancing research in microbiome and probiotic science.
NITI Aayog: The government’s premier policy think tank which represented the official stance on integrating gut health into India's wider development and healthcare goals.
Shri Rajiv Gauba: Member of NITI Aayog and Chief Guest who outlined the critical role of microbiome science in immunity, metabolism, and national health strategy.
Ayushman Bharat: A flagship national health initiative cited for its contribution to strengthening primary healthcare and reducing out-of-pocket health expenditure.
NITI Aayog
Gut Microbiota and Probiotic Science
Foundation organises 16th India Probiotic
Symposium in New Delhi
Posted On: 28 MAR 2026 10:54AM by PIB Delhi
The Gut Microbiota and Probiotic Science Foundation organised the 16th India Probiotic Symposium on
“Gut Microbiome and Probiotics: Impact from Cradle to Centenarians” in New Delhi on March 27–28,
2026.
Delivering the Chief Guest address, Shri Rajiv Gauba, Member, NITI Aayog underscored the critical role
of the gut microbiome in immunity, metabolism and preventive healthcare.
Shri Gauba expressed concern over the rapid shift in dietary habits in India, noting that urbanisation,
changing lifestyles and the increasing consumption of ultra-processed and refined foods often driven by
social media and quick commerce platforms are distancing people from traditional, nutritionally rich diets.
He cautioned that these trends could have serious long-term consequences for gut health highlighting that
an estimated 56.4% of India’s disease burden is attributable to unhealthy or imbalanced diets. He further
warned that if neglected, “micro-organisms could create macro consequences.”
Situating gut health within a wider development context, Shri Gauba described healthcare as the most
critical sector for both individual well-being and economic growth. He stated that India’s demographic
dividend can only be realised with a healthy workforce and timely preparation for active and healthy
ageing as the elderly share of the population rises. He emphasised that investment in health is an
investment in Viksit Bharat and cited initiatives such as Ayushman Bharat, PM-JAY, PM Bharatiya
Janaushadhi Pariyojana and Ayushman Arogya Mandirs have significantly strengthened primary
healthcare and financial protection. He pointed out that out-of-pocket health expenditure has declined
from 62.6% to 39.4% between FY15 and FY22, resulting in savings of over ₹1.25 lakh crore for
households.
At the same time, Shri Gauba acknowledged persistent challenges related to access, equity, affordability,
quality, patient safety and shortages of skilled healthcare professionals. He emphasised that access to
healthcare services continues to be influenced by socio-economic factors. Urging healthcare professionals
to play a proactive role, he called for increased prescription of affordable generic medicines and greater
use of digital health tools, telemedicine, data analytics and AI to expand specialist care to underserved
communities and act as advocates for those lacking access to quality medical services.
Addressing the evolving field of probiotics, Shri Gauba noted that microbiome science has progressed
from descriptive studies to mechanistic and translational research. He highlighted emerging frontiers such
as next-generation microbiome-based therapeutics, synthetic biology and CRISPR-enabled engineering of
probiotic strains with targeted anti-inflammatory and metabolic functions for precision medicine.
However, he cautioned against the growing spread of misinformation and misleading advertisements inthe probiotics and supplements market, urging clinicians and researchers to use their credibility and media
reach to disseminate accurate information, promote healthy dietary habits and champion preventive
lifestyles that reduce the need for expensive diagnostics and procedures.
Highlighting India’s rich heritage of fermented foods and traditional dietary practices, Shri Gauba stated
that the country is uniquely positioned to lead the global probiotic movement by combining traditional
knowledge with genomic and microbiome research to develop clinically validated probiotics. He
underlined the vast public health potential of probiotics to reduce infectious and chronic disease burdens,
improve nutrition and strengthen population immunity. He also stressed that robust collaboration between
academia, industry and regulators is essential to translate scientific advances into safe, effective and
accessible products.
Lauding the participation of young researchers and innovators, Shri Gauba encouraged them to adopt
multidisciplinary and evidence-based approaches to address complex health challenges. He expressed
confidence that the symposium would catalyse new collaborations and reinforce India’s leadership in the
field of microbiome and probiotic science.
****
MJPS/PRK
(Release ID: 2246381) Visitor Counter : 746
Read this release in: Urdu , ही , Gujarati , Telugu